Published in J Virol on November 01, 1994
Foot-and-mouth disease. Clin Microbiol Rev (2004) 4.34
Molecular strategies for interrupting arthropod-borne virus transmission by mosquitoes. Clin Microbiol Rev (2000) 1.17
IRES-driven translation is stimulated separately by the FMDV 3'-NCR and poly(A) sequences. Nucleic Acids Res (2002) 1.09
Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers. J Virol (2007) 0.97
Exploring IRES region accessibility by interference of foot-and-mouth disease virus infectivity. PLoS One (2012) 0.80
Multiple microRNAs targeted to internal ribosome entry site against foot-and-mouth disease virus infection in vitro and in vivo. Virol J (2014) 0.79
Genetic characterization of the cell-adapted PanAsia strain of foot-and-mouth disease virus O/Fujian/CHA/5/99 isolated from swine. Virol J (2010) 0.76
Tailoring the switch from IRES-dependent to 5'-end-dependent translation with the RNase P ribozyme. RNA (2010) 0.75
Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res (1981) 61.59
Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta (1990) 5.55
The novel mechanism of initiation of picornavirus RNA translation. Trends Biochem Sci (1990) 4.95
Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNA. Cell (1985) 4.31
Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins. J Virol (1986) 3.89
Conservation of the secondary structure elements of the 5'-untranslated region of cardio- and aphthovirus RNAs. Nucleic Acids Res (1989) 3.81
Functional analysis of the internal translation initiation site of foot-and-mouth disease virus. J Virol (1990) 3.08
Construction and characterization of poliovirus subgenomic replicons. J Virol (1988) 2.69
Biochemical and genetic evidence for a pseudoknot structure at the 3' terminus of the poliovirus RNA genome and its role in viral RNA amplification. J Virol (1993) 2.65
Structure of the FMDV translation initiation site and of the structural proteins. Nucleic Acids Res (1983) 2.58
Complete nucleotide sequence of the genome of coxsackievirus B1. Virology (1987) 2.49
Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene (1980) 2.44
The replication of picornaviruses. J Gen Virol (1979) 2.03
Effects of cDNA hybridization on translation of encephalomyocarditis virus RNA. J Virol (1987) 2.02
Replication of poliovirus RNA and subgenomic RNA transcripts in transfected cells. J Virol (1992) 1.88
New approaches to vaccination against foot-and-mouth disease. Vaccine (1992) 1.68
Antisense oligonucleotides as antiviral agents. Trends Biotechnol (1992) 1.62
A single nucleotide substitution in the internal ribosome entry site of foot-and-mouth disease virus leads to enhanced cap-independent translation in vivo. J Virol (1993) 1.50
The isolation of two enzyme-ribonucleic acid complexes involved in the synthesis of foot-and-mouth disease virus ribonucleic acid. Proc Natl Acad Sci U S A (1969) 1.45
Defective interfering particles of poliovirus. 3. Interference and enrichment. J Mol Biol (1973) 1.44
Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication. Mol Cell Biol (1990) 1.34
Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation. J Virol (1991) 1.34
Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease. Virus Res (1987) 1.31
Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J Virol (1991) 1.29
Antisense RNA. Crit Rev Biochem Mol Biol (1990) 1.23
Inhibition of human immunodeficiency virus type 1 multiplication by antisense and sense RNA expression. J Virol (1991) 1.14
Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus. Gene (1988) 1.12
Defective interfering particles of poliovirus. IV. Mechanisms of enrichment. J Virol (1973) 1.11
Studies on the infectivity of foot-and-mouth disease virus RNA using microinjection. J Gen Virol (1988) 1.10
Inhibition of gene expression by a short sense fragment. Nucleic Acids Res (1991) 1.06
Antisense oligodeoxynucleotides as antiviral agents. Antiviral Res (1991) 0.98
Antiviral activity and possible mechanisms of action of oligonucleotides-poly(L-lysine) conjugates targeted to vesicular stomatitis virus mRNA and genomic RNA. Nucleic Acids Res (1989) 0.95
Mutant U2 snRNAs of Xenopus which can form an altered higher order RNA structure are unable to enter the nucleus. Exp Cell Res (1987) 0.92
Transient inhibition of foot-and-mouth disease virus infection of BHK-21 cells by antisense oligonucleotides directed against the second functional initiator AUG. Antiviral Res (1993) 0.85
Studies on antisense inhibition of translation in vitro. Anomalies and re-evaluation. FEBS Lett (1992) 0.81
The biological activity of early SV40 antisense RNA and DNA molecules. Curr Top Microbiol Immunol (1989) 0.77
The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene (1985) 3.42
Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology (1983) 3.04
Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J Virol (1994) 2.41
Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J Virol (1988) 1.90
Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies. J Virol (1991) 1.89
Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology (1985) 1.84
Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades. J Virol (1992) 1.72
Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc Natl Acad Sci U S A (1989) 1.71
Involvement of the ftsA gene product in late stages of the Escherichia coli cell cycle. J Bacteriol (1980) 1.66
Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem (1999) 1.59
A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J Gen Virol (1990) 1.57
Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Gene (1986) 1.53
Interaction of the eIF4G initiation factor with the aphthovirus IRES is essential for internal translation initiation in vivo. RNA (2000) 1.51
Difference in glucose sensitivity of liver glycolysis and glycogen synthesis. Relationship between lactate production and fructose 2,6-bisphosphate concentration. Biochem J (1984) 1.49
Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J Exp Med (1999) 1.45
Conserved structural motifs located in distal loops of aphthovirus internal ribosome entry site domain 3 are required for internal initiation of translation. J Virol (1997) 1.38
Relationship of Escherichia coli density to growth rate and cell age. J Bacteriol (1981) 1.38
A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol (1997) 1.36
Early detection of PrPres in BSE-infected bovine PrP transgenic mice. Arch Virol (2003) 1.34
Amber mutation affecting the length of Escherichia coli cells. J Bacteriol (1980) 1.30
IRES interaction with translation initiation factors: functional characterization of novel RNA contacts with eIF3, eIF4B, and eIF4GII. RNA (2001) 1.30
Scrotal heat stress effects on sperm viability, sperm DNA integrity, and the offspring sex ratio in mice. Mol Reprod Dev (2008) 1.29
A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. J Virol (2001) 1.29
Long-range RNA interactions between structural domains of the aphthovirus internal ribosome entry site (IRES). RNA (1999) 1.22
The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene (2000) 1.19
Influence of glucose on the sex ratio of bovine IVM/IVF embryos cultured in vitro. Reprod Fertil Dev (2001) 1.19
Ribavirin cures cells of a persistent infection with foot-and-mouth disease virus in vitro. J Virol (1987) 1.18
Involvement of the aphthovirus RNA region located between the two functional AUGs in start codon selection. Virology (1999) 1.16
Design of primers for PCR amplification of highly variable genomes. Comput Appl Biosci (1993) 1.16
Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus. Gene (1988) 1.12
VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J Virol (1992) 1.10
Sequence of the viral replicase gene from foot-and-mouth disease virus C1-Santa Pau (C-S8). Gene (1985) 1.10
Temporal divergence in the pattern of messenger RNA expression in bovine embryos cultured from the zygote to blastocyst stage in vitro or in vivo. Biol Reprod (2003) 1.09
Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J Virol (1991) 1.07
Different behavior toward bovine spongiform encephalopathy infection of bovine prion protein transgenic mice with one extra repeat octapeptide insert mutation. J Neurosci (2004) 1.06
Gene encoding capsid protein VP1 of foot-and-mouth disease virus: a quasispecies model of molecular evolution. Proc Natl Acad Sci U S A (1988) 1.05
Analysis of differential messenger RNA expression between bovine blastocysts produced in different culture systems: implications for blastocyst quality. Biol Reprod (2002) 1.04
Extensive cell heterogeneity during persistent infection with foot-and-mouth disease virus. J Virol (1989) 1.02
Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology (1999) 1.02
Microinjecting DNA into mouse ova to study DNA replication and gene expression and to produce transgenic animals. Biotechniques (1990) 1.01
Deletion or substitution of the aphthovirus 3' NCR abrogates infectivity and virus replication. J Gen Virol (2001) 1.01
Differential expression of two genes located on the X chromosome between male and female in vitro-produced bovine embryos at the blastocyst stage. Mol Reprod Dev (2000) 1.00
Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression. J Gen Virol (1998) 1.00
Parameters influencing translational efficiency in aphthovirus IRES-based bicistronic expression vectors. Gene (1998) 0.99
SLUG (SNAI2) overexpression in embryonic development. Cytogenet Genome Res (2006) 0.98
Molecular evolution of aphthoviruses. Virus Genes (1995) 0.97
Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine. Virology (1990) 0.96
Developmental consequences of sexual dimorphism during pre-implantation embryonic development. Reprod Domest Anim (2006) 0.96
In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispecies. J Gen Virol (1998) 0.96
Transgenic mice expressing bovine PrP with a four extra repeat octapeptide insert mutation show a spontaneous, non-transmissible, neurodegenerative disease and an expedited course of BSE infection. FEBS Lett (2005) 0.96
Immunogenicity of non-structural proteins of foot-and-mouth disease virus: differences between infected and vaccinated swine. Arch Virol (1994) 0.95
Primer design for specific diagnosis by PCR of highly variable RNA viruses: typing of foot-and-mouth disease virus. Virology (1992) 0.95
Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J Virol (2001) 0.95
Comparison of vaccine strains and the virus causing the 1986 foot-and-mouth disease outbreak in Spain: epizootiological analysis. Virus Res (1990) 0.95
Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. J Gen Virol (1992) 0.94
Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma. Oncogene (2000) 0.93
Transgenic mice secreting coronavirus neutralizing antibodies into the milk. J Virol (1998) 0.93
Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice. Oncogene (2006) 0.93
Association of bovine DRB3 alleles with immune response to FMDV peptides and protection against viral challenge. Vaccine (2000) 0.91
Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes. Virus Res (1989) 0.90
Cyclosporin A inhibits phorbol ester-induced activation of superoxide production in resident mouse peritoneal macrophages. Biochem J (1989) 0.90
Vertical transmission of bovine spongiform encephalopathy prions evaluated in a transgenic mouse model. J Virol (2005) 0.90
Engineering passive immunity in transgenic mice secreting virus-neutralizing antibodies in milk. Nat Biotechnol (1998) 0.89
A RT-PCR assay for the differential diagnosis of vesicular viral diseases of swine. J Virol Methods (1998) 0.89
A method for determining the position and size of optimal sequence regions for phylogenetic analysis. J Mol Evol (1995) 0.89
p53 transactivation of the HIV-1 long terminal repeat is blocked by PD 144795, a calcineurin-inhibitor with anti-HIV properties. J Biol Chem (1998) 0.89
CMV-driven expression of green fluorescent protein (GFP) in male germ cells of transgenic mice and its effect on fertility. Int J Androl (2001) 0.89
Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia. Transl Psychiatry (2013) 0.89
Effect of speed of development on mRNA expression pattern in early bovine embryos cultured in vivo or in vitro. Mol Reprod Dev (2004) 0.89
Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4. J Virol (2000) 0.88
Internal initiation of translation efficiency in different hepatitis C genotypes isolated from interferon treated patients. Arch Virol (1999) 0.88
NO induces a cGMP-independent release of cytochrome c from mitochondria which precedes caspase 3 activation in insulin producing RINm5F cells. FEBS Lett (1999) 0.88
Factors from damaged sperm affect its DNA integrity and its ability to promote embryo implantation in mice. J Androl (2007) 0.87
Differential sensitivity of male and female mouse embryos to oxidative induced heat-stress is mediated by glucose-6-phosphate dehydrogenase gene expression. Mol Reprod Dev (2005) 0.87
Hormonal regulation of fructose 2,6-bisphosphate levels in epididymal adipose tissue of rat. FEBS Lett (1985) 0.87
Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins. J Gen Virol (1999) 0.87
3D gene of foot-and-mouth disease virus. Conservation by convergence of average sequences. J Mol Biol (1988) 0.86
Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. Virology (1994) 0.86
A porcine CD8+ T cell clone with heterotypic specificity for foot-and-mouth disease virus. J Gen Virol (1996) 0.86
Fixation of mutations at the VP1 gene of foot-and-mouth disease virus. Can quasispecies define a transient molecular clock? Gene (1991) 0.86
Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of immunotherapy. J Allergy Clin Immunol (2001) 0.85
Transient inhibition of foot-and-mouth disease virus infection of BHK-21 cells by antisense oligonucleotides directed against the second functional initiator AUG. Antiviral Res (1993) 0.85
Effect of the in vitro culture system on the kinetics of blastocyst development and sex ratio of bovine embryos. Theriogenology (2001) 0.85
Effect of flanking matrix attachment regions on the expression of microinjected transgenes during preimplantation development of mouse embryos. Transgenic Res (2000) 0.84
Development of protection against coronavirus induced diseases. A review. Adv Exp Med Biol (1995) 0.84
Co-ordination between elongation and division in Escherichia coli mediated by the wee gene product. J Gen Microbiol (1984) 0.84
A computer program for the design of PCR primers for diagnosis of highly variable genomes. J Virol Methods (1993) 0.84
Development and pattern of mRNA relative abundance of bovine embryos cultured in the isolated mouse oviduct in organ culture. Mol Reprod Dev (2007) 0.83
Evidence for involvement of c-Src in the anti-apoptotic action of nitric oxide in serum-deprived RINm5F cells. Cell Signal (2001) 0.83
Molecular epidemiology of foot-and-mouth disease virus type O. J Gen Virol (1993) 0.83
Estimates by computer simulation of genetic distances from comparisons of RNAse A mismatch cleavage patterns. J Virol Methods (1993) 0.83
Modulation of the inhibition of respiratory burst in mouse macrophages by cyclosporin A: effect of in vivo treatment, glucocorticoids and the state of activation of cells. Immunology (1991) 0.83
Modulation of phorbol ester-induced respiratory burst by vanadate, genistein, and phenylarsine oxide in mouse macrophages. Free Radic Biol Med (1995) 0.82
Heterotypic inhibition of foot-and-mouth disease virus infection by combinations of RNA transcripts corresponding to the 5' and 3' regions. Antiviral Res (1999) 0.82
Characterization of calcineurin in human neutrophils. Inhibitory effect of hydrogen peroxide on its enzyme activity and on NF-kappaB DNA binding. J Biol Chem (1999) 0.82